AllianceBernstein’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.9K Hold
20,250
﹤0.01% 3184
2025
Q4
$69.9K Hold
20,250
﹤0.01% 3193
2025
Q3
$103K Hold
20,250
﹤0.01% 3176
2025
Q2
$107K Buy
20,250
+6,600
+48% +$48K ﹤0.01% 3164
2025
Q1
$111K Hold
13,650
﹤0.01% 3055
2024
Q4
$175K Hold
13,650
﹤0.01% 3046
2024
Q3
$146K Hold
13,650
﹤0.01% 3082
2024
Q2
$108K Buy
+13,650
New +$130K ﹤0.01% 3115

Other funds holding RCEL

AllianceBernstein's RCEL Position: Q1 2026 in Review

AllianceBernstein held its Avita Medical (RCEL) position steady in Q1 2026 at 20,250 shares worth $69.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3184.

AllianceBernstein first reported a position in RCEL in Q2 2024 and has held it in 8 quarters since. The position peaked at $175K in Q4 2024. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • AllianceBernstein held 20,250 shares of Avita Medical worth $69.9K as of Q1 2026.
  • AllianceBernstein left its Avita Medical share count unchanged in Q1 2026.
  • Avita Medical made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3184 holding.
  • AllianceBernstein first reported a position in Avita Medical in Q2 2024 and has held it in 8 quarters since.
  • AllianceBernstein's Avita Medical position peaked at $175K in Q4 2024.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.